SORL [SORL Auto Parts] 8-K: (Original Filing)
[]
EGT [Entertainment Gaming Asia] 8-K: (Original Filing)
[USE BLACK INK ONLY - DO NOT HIGHLIGHT ABOVE SPACE IS FOR OFFICE USE ONLY For Nevada Profit Corporations 1. Name of corporation: Entertainment Gaming Asia Inc. 3. The current number of authorized shares and the par value, if any, of each class or series, if any, of shares before the change: 300,000,000 shares of common stock, $0.001 par value] [CONTACTS: Entertainment Gaming Asia Inc. Traci Mangini tracimangini@EGT-Group.com 312/867-0848 ENTERTAINMENT GAMING ASIA ANNOUNCES 1-for-4 REVERSE STOCK SPLIT EFFECTIVE JUNE 12, 2012 - Reverse Stock Split Combined with Improved Financial Performance Expected to Enhance Marketability of the Company’s Stock and Long-term Shareholder Value – Hong Kong – June 4, 2012 – Entertainment Gaming Asia Inc. (NYSE MKT: EGT) (“Entertainment Gaming Asia”] []
EGT [Entertainment Gaming Asia] 8-K: USE BLACK INK ONLY – DO NOT HIGHLIGHT
[USE BLACK INK ONLY - DO NOT HIGHLIGHT ABOVE SPACE IS FOR OFFICE USE ONLY For Nevada Profit Corporations 1. Name of corporation: Entertainment Gaming Asia Inc. 3. The current number of authorized shares and the par value, if any, of each class or series, if any, of shares before the change: 300,000,000 shares of common stock, $0.001 par value] [CONTACTS: Entertainment Gaming Asia Inc. Traci Mangini tracimangini@EGT-Group.com 312/867-0848 ENTERTAINMENT GAMING ASIA ANNOUNCES 1-for-4 REVERSE STOCK SPLIT EFFECTIVE JUNE 12, 2012 - Reverse Stock Split Combined with Improved Financial Performance Expected to Enhance Marketability of the Company’s Stock and Long-term Shareholder Value – Hong Kong – June 4, 2012 – Entertainment Gaming Asia Inc. (NYSE MKT: EGT) (“Entertainment Gaming Asia”] []
GSI [GENERAL STEEL] 8-K: (Original Filing)
[General Steel to Restate Certain Items in Accounting Treatment Related to Collaboration with Shaanxi Iron and Steel Group, Co. Ltd. Company to Restate 2009 and 2010 Financial Results; No Material Impact on Sales Revenue; No Impact on Cash Balances Company Expects to File All Outstanding Financial Statements with the SEC and Regain Compliance with NYSE Listing Requirements BEIJING – June] []
GSI [GENERAL STEEL] 8-K: General Steel to Restate Certain Items in Accounting
[General Steel to Restate Certain Items in Accounting Treatment Related to Collaboration with Shaanxi Iron and Steel Group, Co. Ltd. Company to Restate 2009 and 2010 Financial Results; No Material Impact on Sales Revenue; No Impact on Cash Balances Company Expects to File All Outstanding Financial Statements with the SEC and Regain Compliance with NYSE Listing Requirements BEIJING – June] []
TPI [TIANYIN PHARMACEUTICAL] 8-K: (Original Filing)
[Consulting Agreement This agreement (the “Agreement”) dated and effective this 4th day of June, 2012 by and between Tianyin Pharmaceutical Co., Inc, a Delaware corporation (“TPI” or the “Company”), and James T. McCubbin (“Consultant”). Recitals I. TPI desires to obtain consulting and advisory services from Consultant. II. Consultant, on a part time basis, is in the business of providing such] [INDEPENDENT DIRECTOR AGREEMENT OF TIANYIN PHARMACEUTICAL CO., INC. , This INDEPENDENT DIRECTOR AGREEMENT (the “Agreement”) is made and entered into as of this 4th day of June, 2012 (the “Effective Date”), by and between Tianyin Pharmaceutical Co., Inc. WHEREAS, the Company desires to engage the Independent Director, and the Independent Director desires to serve, as a non-employee director of the] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT June 4, 2012 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]
TPI [TIANYIN PHARMACEUTICAL] 8-K: Consulting Agreement This agreement (the “Agreement”) dated and
[Consulting Agreement This agreement (the “Agreement”) dated and effective this 4th day of June, 2012 by and between Tianyin Pharmaceutical Co., Inc, a Delaware corporation (“TPI” or the “Company”), and James T. McCubbin (“Consultant”). Recitals I. TPI desires to obtain consulting and advisory services from Consultant. II. Consultant, on a part time basis, is in the business of providing such] [INDEPENDENT DIRECTOR AGREEMENT OF TIANYIN PHARMACEUTICAL CO., INC. , This INDEPENDENT DIRECTOR AGREEMENT (the “Agreement”) is made and entered into as of this 4th day of June, 2012 (the “Effective Date”), by and between Tianyin Pharmaceutical Co., Inc. WHEREAS, the Company desires to engage the Independent Director, and the Independent Director desires to serve, as a non-employee director of the] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT June 4, 2012 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]
